Malignant Glottis Neoplasm — Trials

Malignant Glottis Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

8 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 2
Recruiting: 2
Ph III recruiting: 0
Growth YoY: —
Industry share: 0%
Top sponsor: Eye & ENT Hospital of Fudan University
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (0)

clinicaltrialsPublishedShowing 1–4 of 4 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07391345	Precision Medicine: MRI-Guided Stereotactic Ablative Radiotherapy (MRI-SABR) for Early-Stage Glottic Laryngeal Cancer(SMART - 1_1)	recruiting	N/A	105	Viktoras RudzianskasOTHER	1	Feb 5, 2026	clinicaltrials
NCT03548285	Stereotactic Ablative Radiotherapy for Early-stage Glottic Larynx Cancer	completed	N/A	25	University of Texas Southwestern Medical CenterOTHER	1	May 22, 2025